Skip to main content
Journal cover image

Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients.

Publication ,  Journal Article
Qiao, EM; Voora, RS; Nalawade, V; Kotha, NV; Qian, AS; Nelson, TJ; Durkin, M; Vitzthum, LK; Murphy, JD; Stewart, TF; Rose, BS
Published in: Cancer medicine
October 2021

Despite guideline recommendations, utilization of low-dose computed tomography (LDCT) for lung cancer screening remains low. The driving factors behind these low rates and the real-world effect of LDCT utilization on lung cancer outcomes remain limited.We identified patients diagnosed with non-small cell lung cancer (NSCLC) from 2015 to 2017 within the Veterans Health Administration. Multivariable logistic regression assessed the influence of LDCT screening on stage at diagnosis. Lead time correction using published LDCT lead times was performed. Cancer-specific mortality (CSM) was evaluated using Fine-Gray regression with non-cancer death as a competing risk. A lasso machine learning model identified important predictors for receiving LDCT screening.Among 4664 patients, mean age was 67.8 with 58-month median follow-up, 95% CI = [7-71], and 118 patients received ≥1 screening LDCT before NSCLC diagnosis. From 2015 to 2017, LDCT screening increased (0.1%-6.6%, mean = 1.3%). Compared with no screening, patients with ≥1 LDCT were more than twice as likely to present with stage I disease at diagnosis (odds ratio [OR] 2.16 [95% CI 1.46-3.20]) and less than half as likely to present with stage IV (OR 0.38 [CI 0.21-0.70]). Screened patients had lower risk of CSM even after adjusting for LDCT lead time (subdistribution hazard ratio 0.60 [CI 0.42-0.85]). The machine learning model achieved an area under curve of 0.87 and identified diagnosis year and region as the most important predictors for receiving LDCT. White, non-Hispanic patients were more likely to receive LDCT screening, whereas minority, older, female, and unemployed patients were less likely.Utilization of LDCT screening is increasing, although remains low. Consistent with randomized data, LDCT-screened patients were diagnosed at earlier stages and had lower CSM. LDCT availability appeared to be the main predictor of utilization. Providing access to more patients, including those in diverse racial and socioeconomic groups, should be a priority.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer medicine

DOI

EISSN

2045-7634

ISSN

2045-7634

Publication Date

October 2021

Volume

10

Issue

20

Start / End Page

7289 / 7297

Related Subject Headings

  • Tomography, X-Ray Computed
  • Male
  • Lung Neoplasms
  • Humans
  • Female
  • Early Detection of Cancer
  • Aged
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Qiao, E. M., Voora, R. S., Nalawade, V., Kotha, N. V., Qian, A. S., Nelson, T. J., … Rose, B. S. (2021). Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients. Cancer Medicine, 10(20), 7289–7297. https://doi.org/10.1002/cam4.4229
Qiao, Edmund M., Rohith S. Voora, Vinit Nalawade, Nikhil V. Kotha, Alexander S. Qian, Tyler J. Nelson, Michael Durkin, et al. “Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients.Cancer Medicine 10, no. 20 (October 2021): 7289–97. https://doi.org/10.1002/cam4.4229.
Qiao EM, Voora RS, Nalawade V, Kotha NV, Qian AS, Nelson TJ, et al. Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients. Cancer medicine. 2021 Oct;10(20):7289–97.
Qiao, Edmund M., et al. “Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients.Cancer Medicine, vol. 10, no. 20, Oct. 2021, pp. 7289–97. Epmc, doi:10.1002/cam4.4229.
Qiao EM, Voora RS, Nalawade V, Kotha NV, Qian AS, Nelson TJ, Durkin M, Vitzthum LK, Murphy JD, Stewart TF, Rose BS. Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients. Cancer medicine. 2021 Oct;10(20):7289–7297.
Journal cover image

Published In

Cancer medicine

DOI

EISSN

2045-7634

ISSN

2045-7634

Publication Date

October 2021

Volume

10

Issue

20

Start / End Page

7289 / 7297

Related Subject Headings

  • Tomography, X-Ray Computed
  • Male
  • Lung Neoplasms
  • Humans
  • Female
  • Early Detection of Cancer
  • Aged
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 0601 Biochemistry and Cell Biology